This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, et al. Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat. 2013; 20(4): 294-296.BrebanRDossWEsmatGElsayedMHellardMAyscuePet alTowards realistic estimates of HCV incidence in EgyptJ Viral Hepat201320429429610.1111/j.1365-2893.2012.01650.xSearch in Google Scholar
Zucker S. Whomsoever ignores the natural history of the hepatitis C virus is doomed to treat it. Gastroenterology. 2002; 122(2): 578-579.ZuckerSWhomsoever ignores the natural history of the hepatitis C virus is doomed to treat itGastroenterology2002122257857910.1016/S0016-5085(02)80326-2Search in Google Scholar
Missiha SB, Ostrowski M, Heathcote EJ. Disease progression in chronic hepatitis C: Modifiable and non-modifable factors. Gastroenterology. 2008; 134(6): 1699-1714.MissihaSBOstrowskiMHeathcoteEJDisease progression in chronic hepatitis C: Modifiable and non-modifable factorsGastroenterology200813461699171410.1053/j.gastro.2008.02.06918471548Search in Google Scholar
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009; 461(7262): 399-401.GeDFellayJThompsonAJSimonJSShiannaKVUrbanTJet alGenetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceNature2009461726239940110.1038/nature0830919684573Search in Google Scholar
Cussigh A, Falleti E, Fabris C, Bitetto D, Cmet S, Fontanini E, et al. Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. Immunogenetics. 2011; 63(1): 33-41.CussighAFalletiEFabrisCBitettoDCmetSFontaniniEet alInterleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis CImmunogenetics2011631334110.1007/s00251-010-0491-721072509Search in Google Scholar
Giannitrapani L, Soresi M, Giacalone A, Campagna ME, Marasà M, Cervello M, et al. IL-6-174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. OMICS. 2011; 15(3): 183-186.GiannitrapaniLSoresiMGiacaloneACampagnaMEMarasàMCervelloMet alIL-6-174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinomaOMICS201115318318610.1089/omi.2010.009321329460Search in Google Scholar
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel poly-morphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998; 102(7): 1369-1376.FishmanDFauldsGJefferyRMohamed-AliVYudkinJSHumphriesSet alThe effect of novel poly-morphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritisJ Clin Invest199810271369137610.1172/JCI26295089849769329Search in Google Scholar
Falleti E, Fabris C, Vandelli C, Colletta C, Cussigh A, Smirne C, et al. Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. Hum Immunol. 2010; 71(10): 999-1004.FalletiEFabrisCVandelliCCollettaCCussighASmirneCet alGenetic polymorphisms of interleu-kin-6 modulate fibrosis progression in mild chronic hepatitis CHum Immunol20107110999100410.1016/j.humimm.2010.06.00620655350Search in Google Scholar
Crystal RG, Brantly ML, Hubbard RC, Curiel DT, Holmes MD. The α1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest. 1989; 95(1): 196-208.CrystalRGBrantlyMLHubbardRCCurielDTHolmesMDThe α1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapyChest198995119620810.1378/chest.95.1.1962642408Search in Google Scholar
Norman MR, Mowat AP, Hutchison D. Molecular basis, clinical consequences and diagnosis of α-1 anti-trypsin deficiency. Ann Clin Biochem. 1997; 34(Pt 3): 230-246.NormanMRMowatAPHutchisonDMolecular basis, clinical consequences and diagnosis of α-1 anti-trypsin deficiencyAnn Clin Biochem199734323024610.1177/0004563297034003039158819Search in Google Scholar
Canva V, Piotte S, Aubert J-P, Porchet N, Lecomte-Houcke M, Huet G, et al. Heterozygous M3Mmalton α1-antitrypsin deficiency associated with end-stage liver disease: Case report and review. Clin Chem. 2001; 47(8): 1490-1496.CanvaVPiotteSAubertJ-PPorchetNLecomte-HouckeMHuetGet alHeterozygous M3Mmalton α1-antitrypsin deficiency associated with end-stage liver disease: Case report and reviewClin Chem20014781490149610.1093/clinchem/47.8.1490Search in Google Scholar
Luisetti M, Seersholm N. α1-Antitrypsin deficiency 1: Epidemiology of α1-antitrypsin deficiency. Thorax. 2004; 59(2): 164-169.LuisettiMSeersholmNα1-Antitrypsin deficiency 1: Epidemiology of α1-antitrypsin deficiencyThorax200459216416910.1136/thorax.2003.006494174693914760160Search in Google Scholar
Fregonese L, Stolk J. Hereditary α1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis. 2008; 3: 16. doi: 10.1186/1750-1172-3-16.FregoneseLStolkJHereditary α1-antitrypsin deficiency and its clinical consequencesOrphanet J Rare Dis2008316doi: 10.1186/1750-1172-3-16Open DOISearch in Google Scholar
Perlmutter DH, May LT, Sehgal PB. Interferon beta 2/interleukin 6 modulates synthesis of α1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J Clin Invest. 1989; 84(1): 138-144PerlmutterDHMayLTSehgalPBInterferon beta 2/interleukin 6 modulates synthesis of α1-antitrypsin in human mononuclear phagocytes and in human hepatoma cellsJ Clin Invest198984113814410.1172/JCI1141333039632472425Search in Google Scholar
Child CG, Turcotte J. Surgery and portal hypertension. Major Probl Clin Surg. 1964; 1: 1-85.ChildCGTurcotteJSurgery and portal hypertensionMajor Probl Clin Surg19641185Search in Google Scholar
Pugh R, Murray Lyon I, Dawson J, Pietroni M, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8): 646-649.PughRMurray LyonIDawsonJPietroniMWilliamsRTransection of the oesophagus for bleeding oesophageal varicesBr J Surg197360864664910.1002/bjs.18006008174541913Search in Google Scholar
Henry R, Chiamori M, Golub O, Berkman S. Revised spectrophotometric methods for the determination of glutamate oxaloacetic transaminase, glutamic pyruvate transaminase and lactic acid dehydrogenase. Am J Clin Pathol. 1960; 34: 381-387.HenryRChiamoriMGolubOBerkmanSRevised spectrophotometric methods for the determination of glutamate oxaloacetic transaminase, glutamic pyruvate transaminase and lactic acid dehydrogenaseAm J Clin Pathol19603438138710.1093/ajcp/34.4_ts.38113713438Search in Google Scholar
Amador E, Wacker WE. Serum glutamic-oxaloacetic transaminase activity. A new modification and an analytical assessment of current assay technics. Clin Chem. 1962; 8(4): 343-350.AmadorEWackerWESerum glutamic-oxaloacetic transaminase activity. A new modification and an analytical assessment of current assay technicsClin Chem19628434335010.1093/clinchem/8.4.343Search in Google Scholar
Bretaudiere J, Vassault A, Amsellem L, Pourci M, Thieu-Phung H, Bailly M. Criteria for establishing a standardized method for determining alkaline phosphatase activity in human serum. Clin Chem. 1977; 23(12): 2263-2274.BretaudiereJVassaultAAmsellemLPourciMThieu-PhungHBaillyMCriteria for establishing a standardized method for determining alkaline phosphatase activity in human serumClin Chem197723122263227410.1093/clinchem/23.12.2263Search in Google Scholar
Landis JB, Pardue HL. Kinetics of the reactions of unconjugated and conjugated bilirubins with p-diazobenzenesulfonic acid. Clin Chem. 1978; 24(10): 1690-1699.LandisJBPardueHLKinetics of the reactions of unconjugated and conjugated bilirubins with p-diazobenzenesulfonic acidClin Chem197824101690169910.1093/clinchem/24.10.1690Search in Google Scholar
Hirai H. Alpha fetoprotein. In: Chu TM, Ed. Biochemical Markers for Cancer. New York, NY, USA: Marcel Dekker Inc. 1982: 23-59.HiraiHAlpha fetoproteinChuTMBiochemical Markers for CancerNew York, NY, USAMarcel Dekker Inc1982235910.2739/kurumemedj.24.SUPPLEMENT_S27Search in Google Scholar
Glasel J. Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. Biotechniques. 1995; 18(1): 62-63.GlaselJValidity of nucleic acid purities monitored by 260nm/280nm absorbance ratiosBiotechniques19951816263Search in Google Scholar
Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: A systematic review and data synthesis. BMC Infect Dis. 2013; 13(1): 288.MohamoudYAMumtazGRRiomeSMillerDAbu-RaddadLJThe epidemiology of hepatitis C virus in Egypt: A systematic review and data synthesisBMC Infect Dis201313128810.1186/1471-2334-13-288Search in Google Scholar
Guerra J, Garenne M, Mohamed M, Fontanet A. HCV burden of infection in Egypt: Results from a nationwide survey. J Viral Hepat. 2012; 19(8): 560-567.GuerraJGarenneMMohamedMFontanetAHCV burden of infection in Egypt: Results from a nationwide surveyJ Viral Hepat201219856056710.1111/j.1365-2893.2011.01576.xSearch in Google Scholar
Meenagh A, Williams F, Ross OA, Patterson C, Gorodezky C, Hammond M, et al. Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. Hum Immunol. 2002; 63(11): 1055-1061.MeenaghAWilliamsFRossOAPattersonCGorodezkyCHammondMet alFrequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South AmericaHum Immunol200263111055106110.1016/S0198-8859(02)00440-8Search in Google Scholar
Barrett S, Collins M, Kenny C, Ryan E, Keane C, Crowe J. Polymorphisms in tumour necrosis factor α, transforming growth factor β, interleukin 10, interleukin 6, interferon γ, and outcome of hepatitis C virus infection. J Med Virol. 2003; 71(2): 212-218.BarrettSCollinsMKennyCRyanEKeaneCCroweJPolymorphisms in tumour necrosis factor α, transforming growth factor β, interleukin 10, interleukin 6, interferon γ, and outcome of hepatitis C virus infectionJ Med Virol200371221221810.1002/jmv.1047212938195Search in Google Scholar
Pereira FA, Silva NNPd, Rodart IF, Carmo TMAd, Lemaire DC, Reis MGd. Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection. J Med Virol. 2008; 80(1): 58-64.PereiraFASilvaNNPdRodartIFCarmoTMAdLemaireDCReisMGdAssociation of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infectionJ Med Virol2008801586410.1002/jmv.2101118041006Search in Google Scholar
Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, Koniaris LG. Paradoxical effects of short and long term interleukin 6 exposure on liver injury and repair. Hepatology. 2006; 43(3): 474-484.JinXZimmersTAPerezEAPierceRHZhangZKoniarisLGParadoxical effects of short and long term interleukin 6 exposure on liver injury and repairHepatology200643347448410.1002/hep.2108716496306Search in Google Scholar
Shaker OG, Sadik NA. Polymorphisms in interleukin 10 and interleukin 28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin therapy. J Gastroenterol Hepatol. 2012; 27(12): 1842-1849.ShakerOGSadikNAPolymorphisms in interleukin 10 and interleukin 28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin therapyJ Gastroenterol Hepatol201227121842184910.1111/j.1440-1746.2012.07273.x23020144Search in Google Scholar
Shalaby SM, Radwan MI, Abdelazim S, Nafee AM. Interleukin-4 polymorphisms and response to combination therapy in Egyptian chronic hepatitis C patients. Cell Immunol. 2012; 276(1): 110-113.ShalabySMRadwanMIAbdelazimSNafeeAMInterleukin-4 polymorphisms and response to combination therapy in Egyptian chronic hepatitis C patientsCell Immunol2012276111011310.1016/j.cellimm.2012.04.00922594992Search in Google Scholar
Abdel-Hady H, El-Naggar M, El-Nady G, Badr R, El-Daker M. Genetic polymorphisms of IL-6-174 and IL-10-1082 in full term neonates with late onset blood stream infections. J Pediatr Infect Dis. 2009; 4(4): 357-365.Abdel-HadyHEl-NaggarMEl-NadyGBadrREl-DakerMGenetic polymorphisms of IL-6-174 and IL-10-1082 in full term neonates with late onset blood stream infectionsJ Pediatr Infect Dis20094435736510.3233/JPI-2009-0203Search in Google Scholar
Helaly MA-H, Hatata E-SZ, Abu-Elmagd M, Ibrahem EF, Alsaid A, El-Aal IAA, et al. Association of IL-10 and IL-6 gene polymorphisms with type 2 diabetes mellitus among Egyptian patients. Eur J Gen Med. 2013; 10(3): 158-162.HelalyMA-HHatataE-SZAbu-ElmagdMIbrahemEFAlsaidAEl-AalIAAet alAssociation of IL-10 and IL-6 gene polymorphisms with type 2 diabetes mellitus among Egyptian patientsEur J Gen Med201310315816210.29333/ejgm/82250Search in Google Scholar
Zekri A, Ashour MS, Hassan A, HM AE-D, El-Shehaby A, Abu-Shady MA. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression. World J Gastroenterol. 2005; 11(42): 6624-6630.ZekriAAshourMSHassanAAE-DHMEl-ShehabyAAbu-ShadyMACytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progressionWorld J Gastroenterol200511426624663010.3748/wjg.v11.i42.6624435575516425355Search in Google Scholar
Settin A, El-Bendary M, Abo-Al-Kassem R, El Baz R. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis. J Gastrointestin Liver Dis. 2006; 15(2): 131-135SettinAEl-BendaryMAbo-Al-KassemREl BazRMolecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosisJ Gastrointestin Liver Dis2006152131135Search in Google Scholar
Gharib AF, Karam RA, Pasha HF, Radwan MI, Elsawy WH. Polymorphisms of hemochromatosis, and α-1 antitrypsin genes in Egyptian HCV patients with and without hepatocellular carcinoma. Gene. 2011; 489(2): 98-102.GharibAFKaramRAPashaHFRadwanMIElsawyWHPolymorphisms of hemochromatosis, and α-1 antitrypsin genes in Egyptian HCV patients with and without hepatocellular carcinomaGene201148929810210.1016/j.gene.2011.08.01021925577Search in Google Scholar
de Serres FJ, Blanco I. Prevalence of α1-antitrypsin deficiency alleles PI* S and PI* Z worldwide and effective screening for each of the five phenotypic classes PI* MS, PI* MZ, PI* SS, PI* SZ, and PI* ZZ: a comprehensive review. Ther Adv Respir Dis. 2012; 6(5): 277-295.de SerresFJBlancoIPrevalence of α1-antitrypsin deficiency alleles PI* S and PI* Z worldwide and effective screening for each of the five phenotypic classes PI* MS, PI* MZ, PI* SS, PI* SZ, and PI* ZZ: a comprehensive reviewTher Adv Respir Dis20126527729510.1177/175346581245711322933512Search in Google Scholar
